908 Devices Inc. (MASS): Operating Cash Flow
-$23.69M
Year ended 2025-12-31
$1.49M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$23.69M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$30.25M | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$25.06M | n/m | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | -$20.93M | n/m | 2024-03-08, From 2022-01-01 |
| 2021-12-31 | -$29.08M | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $4.13M | n/a | 2022-03-11, From 2020-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| 908 Devices Inc. (MASS) | 2025-12-31 | -$23.69M | n/m |
| Harvard Bioscience Inc (HBIO) | 2025-12-31 | $6.73M | +367.3% |
| Rapid Micro Biosystems, Inc. (RPID) | 2025-12-31 | -$31.06M | n/m |
| EyePoint, Inc. (EYPT) | 2025-12-31 | -$240.11M | n/m |
| Bionano Genomics, Inc. (BNGO) | 2025-12-31 | -$16.34M | n/m |
| Precipio, Inc. (PRPO) | 2025-12-31 | $685.0K | +56.0% |
| Quanterix Corp (QTRX) | 2025-12-31 | -$77.24M | n/m |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | -$111.21M | n/m |
| Seer, Inc. (SEER) | 2025-12-31 | -$44.45M | n/m |
Compare MASS, HBIO, RPID, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗